inactivated polio vaccine (IPV)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
adults
children infants |
| gptkbp:alternativeTo |
gptkb:oral_polio_vaccine_(OPV)
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:compatibleWith |
vaccine-derived poliovirus
|
| gptkbp:contains |
inactivated poliovirus
|
| gptkbp:developedBy |
gptkb:Jonas_Salk
|
| gptkbp:features |
immunocompromised individuals
|
| https://www.w3.org/2000/01/rdf-schema#label |
inactivated polio vaccine (IPV)
|
| gptkbp:introduced |
1955
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
redness at injection site mild pain at injection site |
| gptkbp:storage |
2-8°C
|
| gptkbp:type |
killed-virus vaccine
|
| gptkbp:usedFor |
prevention of poliomyelitis
|
| gptkbp:usedIn |
global polio eradication initiative
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:Polio
|
| gptkbp:bfsLayer |
5
|